A panel of international health experts wrapped up a closed-door review this week that could strip the United States of a public health milestone it has held since the year 2000: official measles elimination status. The Pan American Health Organization's regional commission met Nov. 10-13 to examine genomic evidence tracing measles outbreaks across multiple states back to a single, unbroken chain of transmission that health officials warn has run past the one-year mark required to keep the designation.

The review, originally scheduled for April, was pushed to November at the request of U.S. health officials, who said they needed more time to complete genomic sequencing. That delay hasn't changed the underlying math: the CIDRAP infectious disease research center at the University of Minnesota argues the country has effectively already lost elimination, citing a genomic analysis that links a West Texas outbreak which began in January 2025 to a separate Utah outbreak and cases in at least four other states — the two viral strains differing by just 12 letters out of nearly 16,000 in their genetic code.

A record-breaking bad year

The numbers behind the review are stark. The CDC has logged more than 5,100 measles cases so far in 2026, more than double the 2,289 recorded in all of 2025 and the worst U.S. tally since 1991. Researchers and advocacy groups have tied at least eight deaths this year to the virus, several of them infants, and 2025 alone saw the first American measles deaths in decades. Vaccination rates have slipped under the surge: CDC data show just 92.4% of kindergartners got both recommended MMR doses before this school year, short of the 95% threshold needed to block sustained spread, while the agency says 96% of this year's cases occurred in unvaccinated people.

Canada already set the precedent. PAHO stripped Canada's measles-free status in a November 2025 ruling that also cost the entire Americas region its twice-earned elimination title, after Canadian outbreaks were found to be linked by more than a year of continuous spread. The same 12-month continuous-transmission test is now being applied to the U.S. case.

LOSING ELIMINATION STATUS DOES NOT MEAN THAT MEASLES WOULD BE WIDESPREAD

Not everyone in government is treating the review as a crisis. Dr. Ralph Abraham, the CDC's principal deputy director, played down the stakes of a possible reversal, telling reporters the designation change carries no funding cuts or sanctions and does not by itself mean the disease is spreading widely. CDC officials have said they'll keep working with states on vaccination campaigns and outbreak response regardless of PAHO's finding.

Still, the symbolism is significant. The U.S. eliminated endemic measles in 2000, a milestone the CDC has pointed to for a quarter-century as proof the MMR vaccine had beaten back a disease that once killed hundreds of Americans a year before the shot's 1963 introduction. Regaining the status, should it be lost, requires demonstrating a full year without any domestically sustained chain of transmission — meaning even a fast reversal wouldn't restore it before 2028 at the earliest.

PAHO's commission only recommends; the organization's director makes the final call and formally notifies national authorities. No announcement had been made as of Saturday, though health researchers who reviewed the same genomic data say the outcome is effectively a formality at this point.